Related Experiment Video
Updated: Jun 12, 2025
Identification of Circular RNAs using RNA Sequencing
Published on: November 14, 2019
[Research Progress of Circular RNA CircHIPK3 in Non-small Cell Lung Cancer]
1Department of Thoracic Surgery, First Affiliated Hospital of Nanjing Medical University, Nanjing 210000, China.
Abstract:
Lung cancer ranks among the most prevalent and deadliest malignancies worldwide. Despite significant strides in targeted therapies and immunotherapy for lung cancer, curing the disease remains a highly prioritized issue. Circular RNAs (circRNAs), recently discovered RNA molecules characterized by covalently closed loop structures, possess features such as structural stability, sequence conservation, and disease-specific expression. Cutting-edge medical research has linked circRNA dysregulation to the progression of various cancers. Among these, circular RNA HIPK3 (circHIPK3), an oncogenic gene primarily derived from the second exon of the HIPK3 gene, has emerged as a focal point of investigation. Increasing evidences suggest that circHIPK3 is involved in the development of non-small cell lung cancer (NSCLC) and other malignancies. Aberrant expression of circHIPK3 is closely associated with the disease mechanisms, diagnosis, treatment, and prognosis of NSCLC. This review discusses the latest research advancements on circHIPK3 in NSCLC, aiming to promote precise diagnosis and treatment of lung cancer. .
Insights
Circular RNAs (circRNAs) like circHIPK3 show promise in understanding lung cancer. This review explores circHIPK3
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Lung cancer is a leading cause of cancer-related death globally.
- Circular RNAs (circRNAs) are stable, non-coding RNA molecules with disease-specific expression.
- Dysregulation of circRNAs is implicated in various cancers, including lung cancer.
Purpose of the Study:
- To review the latest advancements in the role of circular RNA HIPK3 (circHIPK3) in non-small cell lung cancer (NSCLC).
- To highlight the association of circHIPK3 with NSCLC mechanisms, diagnosis, treatment, and prognosis.
- To promote precise diagnosis and treatment strategies for lung cancer.
Main Methods:
- Literature review of recent studies on circHIPK3 and NSCLC.
- Analysis of evidence linking circHIPK3 expression to cancer progression.
- Synthesis of data regarding circHIPK3's role in NSCLC pathogenesis.
Main Results:
- circHIPK3 is an oncogenic circRNA implicated in the development of NSCLC.
- Aberrant expression of circHIPK3 correlates with NSCLC progression and patient outcomes.
- circHIPK3 shows potential as a biomarker for NSCLC diagnosis and treatment.
Conclusions:
- circHIPK3 plays a significant role in NSCLC development and progression.
- Targeting circHIPK3 may offer novel therapeutic strategies for lung cancer.
- Further research on circHIPK3 is crucial for advancing lung cancer care.
